iPFK2 inhibitors (Cytokine PharmaSciences)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameiPFK2 inhibitors (Cytokine PharmaSciences)
Drug Alias Nameinducible phosphofructokinase 2 inhibitors (Cytokine PharmaSciences)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 inhibitors
Targets6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCytokine Pharmasciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCytokine Pharmasciences
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A